Our Access Advisory Committee assists in our efforts to lower barriers to access to new TB cures.

The Access Advisory Committee (AAC) assists, supports, and advises the TB Alliance on strategies and approaches to achieve adoption, availability, and affordability of new treatment regimens. The group provides ideas, advice, and contacts offering critical thinking on ways to reduce barriers to access.

Jaap Broekmans Johns Hopkins Bloomberg School of Public Health
Gustavo Do Valle Bastos Global Drug Facility
Christy Hanson Bill & Melinda Gates Foundation
Sunil Khaparde Ministry of Health and Family Welfare, India
Carl Mendel TB Alliance
Madhukar Pai McGill Global Health Programs and McGill International TB Centre
Yogan Pillay National Department of Health, South Africa
David Ripin Clinton Health Access Initiative
Joseph Sitienei Ministry of Public Health, Kenya
Alena Skrahina The Republican Research and Practical Centre for Pulmonology and TB, Belarus
Karin Weyer WHO Global TB Programme Unit for Laboratories, Diagnostics and Drug Resistance (LDR)
Andre Zagorski Management Sciences for Health (MSH)

Our Pipeline

TB Alliance manages the largest pipeline of new TB drugs in history.

View the portfolio